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Effect of lactate.buffered peritoneal dialysis fluids on human mesothe-
hal cell interleukin.6 and prostaglandin synthesis. The present study
focused on the evaluation of constitutive and cytokine-stimulated human
peritoneal mesothelial cell (HPMC) IL-6 and 6-keto-PGF1, release
following pre-exposure to peritoneal dialysis fluid (PDF). Exposure of
HPMC to PDF pH 5.2 resulted in a time-dependent increase in cell
cytotoxicity [as assessed by lactate dehydrogenase (LDH) release] and
concomitant inhibition of constitutive and IL-1f3 stimulated IL-6 and
6-keto-PGF1 synthesis. After 15 minutes of exposure to PDF constitutive
and IL-1j3 stimulated IL-6 release were reduced by 32.0 9.7% and
76.0 7.4% (N = 6, P < 0.046 and P < 0.027, respectively). PCR
amplification of reverse transcribed mRNA from HPMC pre-exposed to
PDF pH 5.2 demonstrated suppression of IL-1/3 stimulated IL-6 and
cyclooxygenase (Cox-1 and Cox-2) transcripts. In order to mimic the
dialysis cycle in vivo, an in vitro dialysis system was established. HPMC
were exposed first to control medium, PDF pH 5.2 or PDF 7.3 for 15
minutes and then sequentially to pooled spent peritoneal dialysis effluent
for up to four hours. The cells were subsequently allowed to recover in
control medium for 12 hours in the presence or absence of IL-1j3 or
TNF-n (both at 1000 pg/mI). There was no evidence of significant cell
toxicity as assessed by LDH release during either the 'in vitro dialysis' or
'recovery' phases. Under these conditions short term exposure to PDF pH
5.2 followed by 'in vitro dialysis' resulted in significant inhibition of
cytokine stimulated IL-6 (69.6 18.2 vs. 96.7 27.9 pg/g, N = 13; P <
0.020 for IL-113) and 6-keto-PGF1,, (197.5 89.2 vs. 289.6 114.5 pg/j.Lg,
N = 13; P < 0.020 for IL-113) and 6-keto-PGF1 (197.5 89.2 vs. 289.6
114.5 pg/j.g, N = 13; P <0.003) release when compared to cells incubated
in control medium. Adjustment of the pH of PDF to 7.3 reversed its
inhibitory effects. We conclude that short-term exposure to PDF pH 5.2
significantly inhibits HPMC cytokine and prostaglandin release, an effect
which appears to be related to its initial pH. Repeated exposure to
nonphysiological PDF might impair mesothelial cell function and thus
modulate intraperitoneal inflammatory processes.
The mesothelial cell layer that lines the peritoneal cavity forms
an active biological barrier through which transport of water and
solutes occurs during peritoneal dialysis [1]. With better under-
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standing of its metabolic and secretory abilities it has also become
apparent that the mesothelium plays a pivotal role both in main-
taining peritoneal homeostasis and controlling intra-peritoneal
inflammation. In this respect previous in vitro studies have dem-
onstrated that the peritoneal mesothelial cells synthesize phos-
pholipids [2], proteoglycans [3], prostaglandins [4—6] as well as
regulators of the fibrinolytic cascade [7]. More recently it has been
demonstrated that HPMC stimulated with the peritoneal macro-
phage (PM0) derived cytokines, interleukin-1 and tumor necrosis
factor-a (TNF-a) synthesize both interleukin-6 (IL-6) and inter-
leukin-8 (IL-8) [8—101. The products of the PMØ as well as the
mesothelium, the major resident cell of the peritoneal cavity could
thus both contribute directly to the cytokine network regulating
inflammatory processes within the peritoneal cavity.
The efficacy of CAPD as a treatment of end-stage renal disease
depends on the long-term preservation of the peritoneal mem-
brane as a dialyzing organ. It has been widely reported that the
process of CAPD alters peritoneal ultrastructure [11, 12] and
episodes of peritonitis cause significant damage to the mesothelial
monolayer [13]. Recurrent episodes of peritonitis may markedly
exacerbate these changes and in severe cases lead to irreparable
damage to the membrane, loss of ultrafiltration and treatment
failure [14].
During CAPD, conventional lactate-buffered peritoneal dialysis
fluids (PDF), of a composition which includes low pH, high
osmolality and high glucose concentration, are infused into the
peritoneal cavity. It is postulated that these solutions compromise
host defence mechanisms in vivo [15—18]. Numerous in vitro
studies have also documented the potential of both high and low
glucose in unused PDF to inhibit peripheral and peritoneal
phagocyte viability and function [19—24] as well as examining their
detrimental effects on mesothelial cells and fibroblast viability
[25—271. It is recognized, however, that PDF equilibrates in vitro
following instillation, with a rapid rise in pH, and a modest fall in
osmolality, glucose and lactate concentration. Thus the "toxic"
potential of the fluid may be decreased. Recent evidence clearly
demonstrates that even following intraperitoneal instillation PDF
may remain inhibitory to peritoneal and peripheral phagocyte
functions [18, 28, 29]. Little is known, however, about how
exposure to unused or spent PDF affects the biological function
(cytokine and prostaglandin synthesis) of mesothelial cells or
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whether intraperitoneal equilibration is sufficient to ameliorate
the potential inhibitory effects of dialysis fluids on these cellular
functions.
In order to establish the effects of both unused and spent PDF
on HPMC function, measured as both constitutive as well as
cytokine stimulated IL-6 and prostaglandin release, and viability,
the current study was divided into two parts. First, the time course
of the inhibitory and toxic effects of unused PDF on HPMC (at
pH 5.2 and pH 7.3) was established. Second, we examined
whether the inhibition observed following acute exposure to
unused PDF was persistent despite equilibration of PDF.
Our data demonstrate that as little as 15 minutes of exposure to
unused PDF is sufficient to significantly reduce HPMC ATP levels
and inhibit subsequent cytokine and prostaglandin synthesis.
Following an extended in vitro "recovery period" cell function is
not restored to control levels. This data suggest that repeated
short-term exposure to PDF may impair the function of the
mesothelium and thus modify the homeostasis of the peritoneal
membrane in terms of ultrafiltration and inflammation.
Methods
Unless otherwise stated, all chemicals were obtained from the
Sigma Chemical Company (Poole, Dorset, UK). Recombinant
human IL-1/3 was a gift from Dr. D. Boraschi (Sclavo Research
Centre, Siena, Italy). Its specific activity was 2.5 X i07 U/mg as
assessed in the EL-416/CTLL bioassay. Human TNF-a was ob-
tained from BASF AG (Ludwigshafen, Germany). Its specific
activity was 8 x i0 U/mg protein (as assessed in a 48 hr L929
bioassay in the absence of actinomycin D). All cytokine prepara-
tions were batched and stored at —70°C and freshly thawed for
each experiment. Endotoxin contamination of recombinant ma-
terial was <0.7 pg/g protein as assessed by limulus amoebocyte
lysate assay (Kabi Vitrum, Stockholm, Sweden).
Isolation and culture of human peritoneal mesothelial cells
Human peritoneal mesothelial cells (HPMC) were obtained from
the omental tissue of consenting patients undergoing elective abdom-
inal surgery. The cells were isolated and characterized essentially as
described previously [6, 9, 10]. The cells cultured were identified as
pure mesothelial cells by their uniform cobblestone appearance at
confluence, by the presence of surface microvilli, by the lack of
staining for Factor VIII related antigen and by the uniform positive
staining for cytokeratins 8 and 18. The presence of contaminating
macrophages was excluded following assessment of Fc receptor
expression (using a red cell rosetting assay which was negative in all
mesothelial cell cultures examined). Cells were maintained in Earle's
buffered Medium 199 (Sera Lab/JRH Biosciences Ltd, Crawley, UK)
supplemented with penicillin (100 U/ml), streptomycin (100 g/ml),
L-glutamine (2 mM; Gibco BRL Life Technologies Ltd, Uxbridge,
UK), transferrin (5 jig/mI), insulin (5 jig/ml), hydrocortisone
(0.4 jig/ml; all from Sigma) and 10% vol/vol fetal calf serum (FCS;
Sera Lab Ltd). HPMC cultures were incubated at 37°C in a humid-
ified 5% CO2 atmosphere.
Cells were passaged using trypsin:EDTA:glucose solution
(0.125% wt/vol:0.01% wt/vol:0.1% wt/vol). All data presented are
from experiments performed with cells from the second passage
which had previously been growth arrested as described below.
There was no difference in the reactivity pattern of mesothelial
cell cultures irrespective of passage number; cells were used from
the second passage and not later to maximize cell numbers and to
avoid using cultures containing senescent cells [10].
Establishment of growth arrested HPMC
HPMC were grown to confluence in rat tail collagen [30]
treated 250 ml flasks or in 24-well plates (Falcon; Becton-
Dickinson UK Ltd, Oxford, UK) and then transferred to culture
medium containing 0.1% vol/vol FCS (rest medium) for 48 hours
prior to stimulation. Previous experiments had demonstrated that
at this time point the cells were maintained in a viable (as assessed
by the lack of LDH release and constant cellular ATP levels) but
non-proliferative state (data not shown). Under these conditions
the cells could be maintained for up to 96 hours without any
significant loss of viability [10].
Effect of unused PDF on HPMC function
HPMC monolayers were grown to confluence in 24-well plates
and growth arrested for 48 hours as previously described. Then
they were washed twice with culture medium (0.1% FCS) and
exposed either to control culture medium or unused PDF with a
glucose concentration of 1.36% wt/vol (PDF 1.36%, Baxter,
Healthcare Corp., Round Lake, Illinois, USA), both supple-
mented with 0.1% vol/vol FCS. The PDF was at pH 5.2 or
adjusted to 7.3 with 0.1 M sodium bicarbonate (BDH Chemicals,
Poole, Dorset, UK). Following specified time intervals, 15, 30, 60
and 240 minutes (treatment phase) fluids were removed and
replaced by fresh medium containing 0.1% vol/vol FCS in which
HPMC were incubated for the next 12 hours (recovery phase) in
the presence or absence of IL-1J3 (1000 pg/ml). Thereafter HPMC
supernatants were removed, centrifuged at 12,000 X g and then
stored at —70°C until assayed (with the exception of the LDH
assay which was performed immediately after the incubation). At
the end of the recovery period the cells were washed with PBS
(pH 7.3; Dulbecco; Oxoid Ltd, Basingstoke, UK) and the cellular
protein solubilized with 0.1 N NaOH. Total cellular protein was
estimated in these supernatants using the modified Bradford
method [31]. Repeated cell counts revealed that 1 jig of cellular
protein was equivalent to 3.76 0.56 X i05 cells (N = 20). Each
well of HPMC contained approximately 60 to 80 jig of cell
protein, all data for IL-6 and prostaglandin measurement are
presented corrected for cellular protein content.
Effect of used PDF on HPMC function
The samples of used PDF were obtained from consenting
non-infected CAPD patients (N = 8) using the following tech-
nique. At specified times (15, 30, 60, 120, 240 mm) after
intraperitoneal instillation of 2.0 liters of fresh PDF (Dianeal,
Baxter Healthcare) containing 1.36% wt/vol glucose and no other
additives, at least 100 ml of effluent was allowed to drain into the
dialysis bag. From this volume a 25 ml sample was aspirated
aseptically from the injection port and the remainder of the fluid
was run back into the abdomen. The removed fluid was trans-
ferred to a sterile tube, immediately centrifuged (4000 X g for 30
mm) and filtered through 0.2 jim pore size filter (Minisart,
Sartorius Ltd, Epsom, UK) to remove any cellular material. Equal
volumes of individual samples were pooled and stored in aliquots
at —70°C until required.
Control medium
Control dialysate
PDF 1.36 pH 5.2
PDF 1.36 pH 7.3
0 60 120 160 240
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The methodology and sensitivity of this ELISA has been previ-
ously published [8, 291. The sensitivity of the assay was 20 pg/mi.
Prostaglandin production determination
Constitutive and stimulated 6-keto-PGF1,, release into HPMC
supernatants was assessed by radioimmunoassay using specific
antibodies. The characterization and cross reactivities of these
antibodies have been previously described [321.
LDH assay
Fig. 1. Invitro dialysis system. HPMC were exposed first to either control
culture medium, unused PDF pH 5.2 or PDF pH 7.3 for 15 mm and then
sequentially for corresponding time periods to pooled spent dialysate
obtained from CAPD patients (Methods). The cells were subsequently
allowed to recover in control medium for 12 hr in the presence or absence
of IL-1/3 or TNF-a (both at concentration of 1000 pg/mI). The additional
control group (control-medium) contained HPMC which were sequen-
tially exposed only to culture medium. Symbols are: (U) Control medium;() PDF 1.36 pH 5.2; () PDF 1.36 pH 7.3; () 15' Spent; () 30' Spent;
(U) 60' Spent; (0)120' Spent; (0) 240' Spent.
In vitro dialysis system
In order to mimic the in vivo four-hour peritoneal dialysis cycle,
the following procedure was followed (Fig. 1).
(a) HPMC were first incubated in either control culture medium,
unused PDF pH 5.2 or unused PDF pH 7.3 for 15 minutes.
(b) This fluid was then removed, the HPMC were washed three
times, and subsequently exposed sequentially to pooled,
timed, spent dialysate, for the following intervals (Fig. 1):
(i) 15 minutes of exposure to 15 minutes spent dialysate
(15' Spent)
(ii) 15 minutes of exposure to 30 minutes spent dialysate
(30' Spent)
(iii) 30 minutes of exposure to 60 minutes spent dialysate
(60' Spent)
(iv) 1 hours of exposure to 120 minutes spent dialysate (120'
Spent)
(v) 2 hours of exposure to 240 minutes spent dialysate (240'
Spent)
In order to exclude the effect of mechanical procedures
related to the fluid replacement one group of HPMC were
exposed to control medium (containing 0.1% FCS) instead of
pooled spent dialysate for the four-hour pre-exposure period.
(c) The cells were then washed three times and exposed to control
medium in the presence or absence of IL-1/3 or TNF-a (both at
a concentration of 1000 pg/mI) for 12 hours at 37°C.
(d) Supernatants from these experiments were removed, centri-
fuged at 12,000 x g and then stored at —70°C until assayed
for IL-6 or prostaglandins or used immediately for LDH
measurement. Cell layers were extracted with 0.1 N NaOH for
protein determination as previously described.
IL-6 production measurements
Constitutive and cytokine stimulated IL-6 release was deter-
mined in the culture supernatants using specific sandwich-ELISA.
LDH activity was measured in the culture supernatants using a
microtitre plate reader (MR 5000/340; Dynatech Laboratories,
UK Ltd, Billingshurst, UK) as described previously [24]. Briefly,
150 l of supernatant was incubated, in triplicate, in a microtiter
plate with 20 sl of 4.0 mtvi f3-nicotinamide adenine dinucleotide
(reduced form; NADH; Sigma) and 10 pA of 7.2 m sodium
pyruvate for 12 minutes at 25°C. At one minute intervals the
optical density was assessed at 340 nm and the resulting negative
O.D. gradient calculated. LDH release was calculated as a
percentage of the gradient obtained after sonication of untreated
HPMC in parallel wells.
Assay of cellular ATP
Second passage HPMC were grown to confluence in 24 well
plates, growth arrested and exposed to PDF pH 5.2 and pH 7.3 for
periods up to 30 minutes. The cells were subsequently washed
three times and allowed to recover in control medium (containing
1.0% FCS) for four hours at 37°C. Following the initial exposure
period and after a 30, 60, 120, 180 and 240 minute "recovety
periods" total cellular ATP was extracted and measured in control
and PDF exposed HPMC using a modification of the method
previously described [331. Briefly, HPMC supernatants were re-
moved and 250 p1 of BAC-extract was added to the cell layer to
extract ATP. Subsequently, 250 i.tl of 25 mM Hepes/lO mM EDTA
was added to stabilize the extracted ATP. The ATP content was
measured by adding 25 td firefly bioluminescence reagent (ATP
Bioluminescence CLS reagent; Boehringer Mannheim, Germany)
to 25 pA of extracted sample and measured using a Lumac/3M
Biocounter M2010 (Lumac, Landgraaf, The Netherlands). Under
the conditions used there was a direct correlation between relative
light units (RLU) and ATP concentration determined using the
internal ATP standard supplied (y = 13610x°472, r = 0.992). The
average ATP content/gg HPMC protein was 4.75 0.70 pmol/g
(mean SEM, N = 10 separate HPMC donors).
RNA isolation, reverse transcription (RT) and PCR amplification
HPMC were grown to confluence in 25 cm2 flasks (Falcon,
Becton-Dickinson), growth arrested as previously described and
exposed to control medium, PDF 1.36% pH 5.2 or PDF 1.36% pH
7.3 (all containing 0.1% FCS) for 15 minutes at 37°C. The cells
were subsequently washed in culture medium and allowed to
recover in culture medium in the presence of IL-lp (1000 pg/mi)
for 12 hours at 37°C. At defined time periods total cellular RNA
was extracted from both control and PDF treated HPMC follow-
ing lysis with 4 M guanidine isothiocyanate and centrifugation
through 5.7 M caesium chloride in 0.1 M EDTA [341. Total RNA
was reverse transcribed into cDNA with M-MLV°° reverse tran-
scriptase (Gibco Life Technologies Ltd, Paisley, UK), using the
random hexamers method as previously described [35]. Briefly,
the reaction mixture contained 1 pA random hexamers (100 p.rvl;
Pharmacia Biosystems Ltd, Milton Keynes, UK), 5 uJ NTP's
(2.5 mM; Gibco/BRL Life Technologies, Ltd), 2 .tl lOx PCR
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Table 1. Amplification primer sequences
Product
Gene Primers size Reference
IL-6 F-TACATCCCTCGACGGATCTC
R-GCTACAmGCCGAAGAGCC
465 bp
[36]
Cox-1 F-GGCCTFGGGCCATGGGGTAG 318 bp
Cox-2
R-AGCTGCTCATCGCCCCAGGT
F-AACCCACTCCAAACACAGTG
R-CTGGCCCTCGCTFATGATCT
411 bp
[37]
[38]
a-Actin F-GGAGCAATGATCTFGATCTT
R-TCCTGAGGTACGGGTCCTITCC
204 bp
[35]
Fig. 3. A. Effect of increasing exposure time to PDF 1.36 pH 5.2 (n), PDF
1.36 pH 7.3 (LII), or control medium (•) on the subsequent release of
6-keto-PGF1from unstimulated HPMC. The data presented are the mean
(±sEM) from 6 separate experiments with HPMC prepared from separate
omental specimens. B. Effect of increasing exposure time to PDF 1.36 pH
5.2 (a), PDF 1.36 pH 7.3 (LII), or control medium (U) on the release of
6-keto-PGF1 from HPMC stimulated with IL-1J3 (1000 pg/mI). The data
presented are the mean (±sEM) from 6 separate experiments with HPMC
prepared from separate omental specimens. There was a statistically
significant difference compared to control HPMC 6-keto PGF1 release at
the same time point with *p < 0.046 or **p < 0.027.
Fig. 2. (A).Generation of IL -6 from unstimulated HPMC following exposure
to PDF 1.36 pH 5.2 (), PDF1.36 pH 7.3 (LI), or control medium (U) for
increasing times. The data presented is the mean (± SEM), IL-6 release
expressed as pg/.g cell protein, from 6 separate experiments with HPMC
prepared from separate omental specimens. There was a statistically
significant difference compared to control HPMC IL-6 release at the same
time point with * < 0.046 or °P < 0.027. (B). Generation of IL-6 from
IL-1f3 (1000 pg/mI) stimulated HPMC following exposure to PDF 1.36 pH
5.2 (n), PDF 1.36 pH 7.3 (LI), or control medium (•) for increasing
times. The data presented are the mean (±sEM), IL-6 release expressed as
pg4tg cell protein, from 6 separate experiments with HPMC prepared
from separate omental specimens. A statistically significant difference
compared to control HPMC IL-6 release at the same time point is *P <
0.046 or * *P < 0.027. The P values on the figure refer to the significant
difference between pH 5.2 and pH 7.3.
buffer (100 mM Tris/HCI, 500 mrvi KC1, 15 mivt MgCl2 and 0.01%
wt/vol gelatin), 2 xl DII (0.1 M; Gibco/BRL Life Technologies,
Ltd), 1 xl RNAase inhibitor (Promega, Southampton, UK), I d
M-MLVTM Superscript reverse transcriptase (200 U; Gibco/BRL
Life Technologies, Ltd) and 1 g of total RNA.
PCR amplification was performed in a total volume of 50 xl
(2 x1 of reverse transcription product and 48 jxl of master mix
(36.25 p1 H20, 1.25 x1 5'-primer (20 f.LM), 1.25 pi 3'-primer (20
.LM), 4 td NTP's, 5 j.tl 10 x PCR buffer and 0.25 pi Taq
polymerase (2.5U, Amplitaq, Applied Biosystems, Warrington,
UK) using a Perkin Elmer 480 Thermocycler (Perkin Elmer
Cetus, Applied Biosystems). The PCR protocol was as follows:
first cycle 72°C for 10 minutes, second cycle, 94°C for 3 minutes,
55°C for 1 minute, 72°C for 1 minute; third, 30th cycles 94°C for
40 seconds, 55°C for 1 minute, 72°C for 1 minute. The final cycle
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Fig. 4. Effect of increasing exposure time to PDF 1.36 pH 5.2 (), PDF1.36
pH 7.3 (LI), or control medium (•) on the release of LDH from HPMC
during the subsequent recovely phase (12 hr). *A statistically significant
difference compared to control LDH release with P < 0.027. The data
presented are the mean (±saM), % LDH release from 6 separate
experiments with HPMC prepared from separate omental specimens.
was 94°C for 1 minute and 60°C for 10 minutes. PCR was
performed for various cycles [25—30]. One-tenth of the PCR
reaction from both test (IL-6ICox) and control (a-actin) product
were mixed and separated by flat bed electrophoresis in 1.5%
wt/vol NuSieve GTG agarose gels (Flowgen Instruments Ltd,
Sittingbourne, UK), stained with ethidium bromide (Sigma) and
photographed. The negatives were scanned using a densitometer
(Model 620 video densitometer, Bio-Rad Laboratories Ltd) and
the density of the bands compared to those of the housekeeping
gene.
Oligonucleotide synthesis
The sequences of the amplification primers are in Table 1.
Statistical analysis
All data were derived from experiments with HPMC prepared
from at least six separate donors. All statistical analyses were
performed using the Wilcoxson matched-pairs signed ranks test
(Statview 512+ Apple Macintosh Inc., Cupertino, USA), a P
value of less than 0.05 being considered as significant. All data are
presented as mean (±sEM).
Results
Unused PDF
Effect of unused PDF on HPMC IL-6 synthesis. Following
exposure of HPMC to PDF (1.36% glucose) pH 5.2, both
constitutive and IL-1/3 stimulated IL-6 release were reduced in a
time-dependent manner (Fig. 2). This inhibition was significant
after only 15 minutes of exposure, both in unstimulated and IL-1f3
stimulated HPMC. The degree of inhibition (compared to control
medium) continued to increase over the whole time course
studied. After a four hour exposure constitutive and IL-13
stimulated HPMC IL-6 release were reduced by 93.7 2.2% and
97.3 0.5%, respectively (N = 6, z = 2.201; P < 0.027 for both).
Exposure of HPMC to 1.36% glucose PDF pH 7.3 for 15
minutes did not diminish constitutive IL-6 release; however, over
the same time period IL-lp stimulated IL-6 release was signifi-
cantly reduced. Longer incubation of HPMC with PDF pH 7.3
resulted in a time-dependent decrease in IL-6 release up to a
Fig. 5. A. Effect of increasing exposure time to PDF 1.36 pH 5.2 or control
medium on HPMC total cellular ATP. The data presented are the mean
(±sEM) total cellular ATP (expressed as pmol/g cell protein) from 5
separate experiments with HPMC prepared from separate omental spec-
imens. *A statistically significant difference compared to control ATP
(M199) with P < 0.05. B. Recovery of HPMC total cellular ATP following
increasing time of exposure to PDF pH 5.2. The data presented are the
mean (±sEM) total cellular ATP (expressed as pmol/tg cell protein) from
5 separate experiments with HPMC prepared from separate omental
specimens. Symbols are: (O) control; (0) 5 minute exposure; (LII) 10
minute exposure; (A) 15 minute exposure.
maximum of 88.3 4.0% inhibition (N = 6,z = 2.201; P < 0.027).
The degree of inhibition was always significantly less than that
induced following treatment with PDF pH 5.2 (Fig. 2B).
Effect of unused PDF on HPMC prostaglandin synthesis. Expo-
sure of HPMC to either PDF pH 5.2 or PDF pH 7.3 for up to 240
minutes did not have any significant effect on constitutive 6-keto-
PGF1 release (as assessed by RIA) during the 12-hour recovery
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CON PDF
pH 5.2
PDF
pH 7.3
-PCR
period following acute exposure (Fig. 3A). Exposure to PDF pH
5.2, however, resulted in a time-dependent decrease in IL-13
stimulated 6-keto-PGF1 generation (Fig. 3B).
Adjustment of the pH of PDF to 7.3 markedly reduced this
inhibitory effect but did not return it to control levels. After 240
minutes of exposure cytokine stimulated 6-keto-PGF1 release
was reduced in PDF pH 5.2 treated HPMC (84.2 22.4%
inhibition) and in HPMC exposed to PDF pH 7.3 (58.4 19.1%
inhibition; Fig. 3B).
Viability assays: LDH release. Neither PDF at pH 5.2 or at pH
7.3 increased LDH release from HPMC during the 240 minutes of
exposure to unused PDF (data not shown). During the 12 hour
recovery phase, however, LDH release became significantly ele-
vated for all unused PDF pre-exposure periods (15, 30, 60 and 240
mm) at pH 5.2. After 15 minutes pre-exposure, LDH release was
increased by 1.9 0.4-fold above control (21.2 3.9%; N = 6,
z = 2.201; P < 0.027). This release continued to increase in a time
dependent fashion and had reached 3.0 0.3-fold above control
after 240 minutes pre-exposure (N = 6, z = 2.201; P < 0.027; Fig.
4).
Pre-exposure to PDF pH 7.3 also augmented LDH release but
only after exposure of HPMC to unused PDF for 60 minutes or
longer. After 240 minutes of pre-exposure the percent LDH had
increased from 17.4 4.7% for control cells to 36.9 9.9%
following pre-exposure to PDF pH 7.3 (N = 6, z = 2,201; P <
0.027). Over the whole time course studied LDH release induced
by PDF pH 5.2 was significantly higher than that which followed
exposure to PDF with pH adjusted to 7.3 (Fig. 4).
Cellular A TP. Exposure of HPMC to PDF pH 5.2 resulted in a
time dependent decrease in total cellular ATP, as assessed using
the firefly bioluminescence assay. After 5 minutes of exposure
HPMC ATP was decreased by a mean of 15.9% (N = 5, z = 1.96,
P = 0.046). Increasing exposure time to 15 and 30 minutes
resulted in further decreases in cellular ATP (88.1 and 99.9%
inhibition), respectively, (N = 5, z = 1.96,P = 0.046 for both; Fig.
5A).
To assess the ability of HPMC to recover their cellular ATP
content (as measured during the recovery period) following acute
exposure to dialysis fluids. HPMC were exposed to PDF pH 5.2 or
7.3 for 15 minutes, washed three times and subsequently allowed
to recover in control medium for up to 240 minutes.
Exposure of HPMC to PDF pH 5.2 for 15 minutes resulted in
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a reduction of cellular ATP content from 5.4 0.4 in control cells
to 0.6 0.02 pmoI/g protein (88.4% inhibition; N 5, z = 1.96;
P < 0.046). In contrast exposure of HPMC to PDF pH 7.3 did not
significantly reduce cellular ATP content (5.3 0.5 pmol/jg
protein).
Following acute (15 mm) exposure to PDF pH 5.2 HPMC ATP
content was assessed over a four hour period. During this
"recovery phase" total cellular ATP increased in a time depen-
dent manner but only returned to control levels by the end of the
recovery period (240 mm; Fig. SB). Shorter exposure periods to
PDF pH 5.2 also resulted in a reduction in cellular ATP levels
[2.47 0.25 and 2.1 0.2 pmol/j.g protein for 5 and 10 mm
exposure (54.6 and 60.7% reductions), respectively; z 1.96, P <
0.046 for both]. These levels returned to those of controls after a
120 minute recovery period (4.6 0.42 pmol/g protein and 5.5
0.4 pmol/j.g protein), respectively.
RTIPCR. Stimulation of HPMC with IL-1f3 resulted in a time
dependent increase in IL-6 and Cox mRNA expression, reaching
steady state between three and six hours post-stimulation (data
not shown). Following 15 minutes exposure to PDF pH 5.2 or
PDF pH 7.3 and subsequent stimulation there was a reduction in
IL-113 induced steady state IL-6 specific mRNA transcripts corn-
pared to cells exposed to control medium (Fig. 6). Exposure to
PDF pH 5.2 but not PDF pH 7.3 resulted in a small reduction in
both Cox-1 and Cox-2 steady state mRNA levels as assessed by
RT/PCR (Fig. 7).
Used PDF
In vitro dialysis. We did not observe any significant differences,
in terms of IL-6, 6-keto:PGF1, or LDH release, between HPMC
exposed first to control medium for 15 minutes and then to spent
dialysates and HPMC incubated throughout the experiment only
in control medium (data not shown). This allowed us to exclude
the direct effect of repeated fluid exchanges on HPMC functional
parameters.
Under in vitro dialysis conditions constitutive IL-6 production
(assessed after recovery period) was reduced by a mean of 31.3
14.2% in cells exposed to PDF pH 5.2 for the first 15 minutes of
the in vitro dialysis cycle (N = 13, z = 2.271; P < 0.025; Fig. 7). In
IL-1/3 and TNF-a stimulated HPMC IL-6 release was reduced by
means of 28.1 17.5% and 38.6 12.4%, respectively (N = 13,
z 2.271, P < 0.025 for both) following exposure to PDF pH 5.2
for the first 15 minutes of the in vitro dialysis cycle.
Constitutive IL-1f3 or TNF-a stimulated HPMC IL-6 secretion
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was not different in HPMC exposed to PDF pH 7.3 (for the first
15 mm of the in vitro dialysis cycle) when compared with control
levels (Fig. 8). Cytokine stimulated HPMC IL-6 release following
exposure to PDF pH 7.3 were higher than observed in HPMC
exposed previously to PDF pH 5.2; however, this was only
statistically significant following IL-113 stimulation (98.8 28.9 vs.
69.6 18.2 pg/j.g cell protein, N = 13, z = 2.48; P < 0.013).
In vitro dialysis, either with PDF pH 5.2 and pH 7.3, did not
have any effect on constitutive 6-keto-PGF1 production by
HPMC (Fig. 9). Following IL-1/3 or TNF-a stimulation, however,
HPMC 6-keto-PGF1 release was significantly reduced by means
of 31.9 29.1% and 26.9 17.9% (N = 11, z = 2.934;P < 0.003
and N = 11, z = 2.045; P < 0.041), respectively, following initial
exposure to PDF pH 5.2.
Initial exposure to PDF pH 7.3 followed by in vitro dialysis and
recovery did not result in any inhibition of cellular responsiveness
as assessed by 6-keto-PGF1 release compared to control in vitro
dialysis. Cytokine stimulated HPMC 6-keto-PGF1a release was
higher than that observed in HPMC exposed previously to PDF
pH 5.2; however, this was only significant following IL-lp stimu-
lation (197.5 89.2 vs. 266.5 109.4 pg/pjg cell protein, N = 11,
z = 2.934; P < 0.003; Fig 9).
LDH release was not increased during any of in vitro dialysis
exposure phases or during the recovery/stimulation period (the %
of total intracellular LDH were 5.2 0.7 in control HPMC, 6.3
1.5 and 4.8 0.8 in HPMC exposed to PDF pH 5.2 or pH 7.3,
respectively). None of these differences were statistically signifi-
cant. When cellular ATP content was assessed, pre-exposure of
HPMC to PDF pH 5.2 for 15 minutes followed by recovery in four
hours of "in vitro dialysis" resulted in an initial drop in cellular
ATP levels which returned to those of the control between 120
and 180 minutes of recovery period (data not shown).
Discussion
Conventional lactate buffered PDF is both cytotoxic and inhib-
itory to a number of cellular functions [17]. While many of these
effects have been documented for phagocytic cells, it has also
become clear that the cells of the peritoneal membrane (mesothe-
hal cells and fibroblasts) may also be sensitive to the detrimental
effect of dialysis solutions [25—27].
It is well documented that the mesothelium in patients under-
going peritoneal dialysis is physically altered after the commence-
ment of treatment. These changes do not only appear to be
attributable to infective episodes as they also occur in its absence
[11, 13, 14]. It is thus possible that repeated exposure to unphys-
iological dialysis solutions might have significant effects on the
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long term function of the peritoneum as a dialysing membrane. In
addition, little is known about the effects of the peritoneal dialysis
milieu, and dialysis fluids in particular, on the inflammatory
function of the mesothelium or whether the peritoneal cytokine
network is modified by repeated exposure to PDF [39]. It has been
suggested that the PM0 forms the first line of defence against
invading microorganisms and that cytokines derived from these
cells provide the initial signals for the activation of mesothelium
and subsequent amplification of intra-peritoneal inflammation
_________ [10, 39, 40]. Recent observations suggest that the stimulation of
_________ HPMC by PMØ supernatants is attributable to their IL-i and
TNFs content [10, 40] and that these stimulatory events can be
mimicked by addition of recombinant cytokines [8—10, 401. The
current study therefore examined the effects of PDF on HPMC
viability and inflammatory function as assessed by both constitu-
tive and cytokine stimulated IL-6 and prostaglandin release.
Exposure of HPMC to unused PDF pH 5.2 resulted in a time
dependent loss of viability as assessed by lactate dehydrogenase
release, confirming earlier studies [26, 27]. Adjustment of the pH
to 7.3 significantly diminished the cytotoxic effect induced by short
term exposure to PDF; however, longer exposure to PDF pH 7.3
also resulted in significant toxicity. These data suggest that while
the pH of PDF may be primarily responsible for its short term
toxic effects, other mechanisms, including lactate concentration,
hyperosmolality or the presence of glucose breakdown products,
might also be responsible for the observed inhibitory effects [25,
41, 42].
We were unable to demonstrate injury to HPMC when mea-
sured by LDH release, during acute exposure to unused PDF.
This may be due in part to the protective effect of the FCS added
to maintain background viability. In addition, it may be related to
the time necessary for significant quantities of LDH to pass across
damaged cytoplasmic membranes. When cell viability/energy me-
tabolism was assessed by measurement of total cellular ATP [43],
however, it was clear that a significant lowering of ATP levels
occurred after as little as five minutes of exposure to PDF pH 5.2.
In the clinical setting of CAPD, it is known that the nonphysi-
ological composition of the instilled dialysis fluids is progressively
equilibrated with increasing dwell time. Its low pH is normalized
within the first 30 minutes [20], suggesting that such a short
exposure in the face of rapid equilibration is not sufficient to
impair cell function in vivo. Recent studies by de Fijter et al
confirm that inhibitory effects do occur in vivo, since even after in
vivo equilibration of infused PDF (30—60 mm dwell time) there
was significant inhibition of peritoneal macrophage phagocytic
and killing capacity cx vivo [18, 28, 44, 45]. This clearly indicates
that acute exposure is sufficient to impair cell function and
indicates that those inhibitory components delineated in vitro
(acidic pH, hyperosmolality and/or glucose concentration) medi-
ate the inhibition of cell function in vivo. [24, 41, 46].
HPMC ATP levels were significantly reduced by as little as five
minutes of exposure to PDF, suggesting that even brief exposure
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Fig. 7. PCR amplification of HPMC mRNA following 15 minutes PDF
exposure: (A) IL-6/a-actin; (B) Cox-1/a-actin; and (C) Cox-2/a-actin. Data
are presented as the IL-6, Cox-1 or Cox-2/a-actin ratios calculated after
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stimulation time point. A representative experiment of three performed
with HPMC from different donors is presented.
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Fig. 8. Effect of 'in vitro dialysis' on the release
of IL-6 from unstimulated HPMC (A), or from
cells exposed to IL-1(3 (1000 pg/mI) or TNF-a
(1000 pg/mI) (B) during the subsequent recovely
phase (12 hr). The data presented are the mean
(±sEM), IL-6 release from 13 separate
experiments with HPMC prepared from
separate omental specimens. * A statistically
significant difference compared to control IL-6
release. Symbols are: (U) control; () PDF
1.36% pH 5.2; (11) PDF 1.36% pH 7.3.
P<0.003
IL-113 TNFu
Fig. 9. Effect of 'in vitro dialysis' on the release of 6-keto-PGF1, from
unstimulated HPMC, or from cells exposed to IL-1f3 (1000 pg/mI) or TNF-a
(1000 pg/mI) during the subsequent recove,y phase (12 hr). The data
presented is the mean (±saM), 6-keto-PGF1, release from 13 separate
experiments with HPMC prepared from separate omental specimens.
There was a statistically significant difference compared to control HPMC
6-keto PGF1 release with * < 0.041 or < 0.003. Symbols are: (U)
control; () PDF 1.36% pH 5.2; (D) PDF 1.36% pH 7.3.
may be sufficient to impair cellular metabolic function. The levels
of cellular ATP returned to control levels by between two and four
hours incubation in control medium or in spent dialysate, suggest-
ing that HPMC are able to recover their cellular energy metabo-
lism and are not irreversibly damaged by acute exposure to PDF.
The fact that this 'recovery' occurs in spent dialysate suggests that
this process might also occur in vivo and may possibly explain why
the mesothelium is not irrevocably destroyed by the dialysis
procedure. Despite this apparent recovery, exposure of HPMC to
unused PDF for as little as 15 minutes was sufficient to signifi-
cantly reduce both constitutive and IL-1/3 stimulated production
of IL-6 and stimulated 6-keto-PGF1,, synthesis even after a
12-hour recovery period in control medium. Adjustment of the
pH of PDF to 7.3 reversed these inhibitory effects. These obser-
vations suggest, as with the ATP data, that pH is a significant
inhibitory component of PDF, confirming previous data on cyto-
kine release from PDF exposed mononuclear leukocytes [29,
47—49].
One obvious shortcoming of previous experiments with unused
PDF is the fact that cells are exposed to the test fluids continually,
which does not mimic the equilibration of PDF seen in vivo. To
overcome this limitation we developed an "in vitro dialysis"
system. In this model the acidic pH of PDF increases rapidly and
mirrors in vivo change in intraperitoneal pH more closely [50].
Under these conditions, short term exposure to PDF pH 5.2 also
resulted in a decrease in both basal and stimulated HPMC IL-6
production and an inhibition of stimulated 6-keto-PGF1, release.
Adjustment of the pH of PDF to 7.3 reversed these effects.
During in vitro dialysis the inhibition of IL-6 and 6-keto-PGF1
production was not associated with an increase in LDH release,
this suggests that the observed loss of cell responsiveness was not
related to cell death.
The mechanism of PDF mediated modulation of HPMC func-
tion remains to be fully elucidated. In leukocytes, the effects of
osmolality, lactate concentration, pH and glucose concentration
are well delineated [24, 46]. In mesothelial cells the situation is
less clear, although it has been demonstrated that high glucose
concentrations per se reduce HPMC proliferation [41] and in-
creased cell death [26]. The roles of lactate, pH and osmolality
remain to be fully investigated. It is clear that even short-term
exposure to PDF is capable of significantly reducing HPMC
function even after an extended recovery period, and that this
inhibition, in terms of IL-6 and prostaglandin synthesis, is related,
at least in part, to a reduction in steady state mRNA levels. These
data confirm recent observations in mononuclear cells where
exposure to PDF reduced cytokine steady state mRNA levels [51].
Further investigation will be required to identify the mecha-
nism(s) of these inhibitory phenomena, although a common
mechanism in lactate buffered PDF may be the transient reduc-
tion of cellular ATP levels as a direct or indirect effect of
intracellular acidification mediated by the low pH and high lactate
concentration present in PDF [24, 52].
These data suggest that in the clinical setting of CAPD that
repeated acute exposure of the peritoneum to the currently
available nonphysiological dialysis solutions leads to modulation
of HPMC function and might thus impair the complex balance of
mediators controlling intraperitoneal inflammation [39]. It is well
recognized that the process of CAPD alters peritoneal membrane
ultrastructure, an observation which suggests that the function of
the mesothelium may be altered during this form of treatment.
Repeated modulation of HPMC function mediated by PDF may
be important in the aetiology of the loss of membrane function
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frequently observed in CAPD patients. More physiological dialy-
sis solutions might limit these potential deleterious effects and
preserve host defence as well as the long-term function of the
peritoneal membrane in CAPD patients.
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